Cliodhna McCann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cliodhna McCann has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Chris I. R. Gill
School of Biomedical Sciences, Ulster University, Coleraine BT52 1SA, Northern Ireland, UK
2 shared publications - James Davis
School of Engineering, Ulster University, Belfast, UK
2 shared publications - Karl McCreadie
School of Computing, Engineering and Intelligent Systems, Ulster University, Derry/Londonderry BT48 7JL, Northern Ireland, UK
2 shared publications - Victoria Gilpin
School of Engineering, Ulster University, Belfast BT15 1ED, Northern Ireland, UK
2 shared publications - Ellen Elizabeth Anne Simpson
School of Psychology, Ulster University, Coleraine BT52 1SA, Northern Ireland, UK
1 shared publication - Erika Rosbotham
School of Biomedical Sciences, Ulster University, Coleraine BT52 1SA, Northern Ireland, UK
1 shared publication
Latest Publications
- Open Access
- 15 September 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (18) , 3019
National Prescribing Patterns in Stoma Care Across the United Kingdom: A Prescription Cost Analysis with Health Policy Implications
Objectives: The prevalence of stoma formation in the United Kingdom has risen markedly over the past decade, yet comparatively little is known about national prescribing patterns for ostomy products. A retrospective cross-sectional observational study was conducted in which the UK Prescription Cost Analysis (PCA) data for 2023 were examined to assess what information can be extracted from these datasets, to evaluate inter-nation variation in prescribing, and identify areas warranting further health economics and policy investigation. Methods: PCA data for calendar year 2023 were collated from the four devolved UK health services. Data on product type, manufacturer, quantities dispensed, and cost were compared across nations and product categories. Results: Total UK prescription spend on ostomy products in 2023 was £457 million, 3.4% of overall NHS prescription expenditure. Pouches accounted for 72% (£329 million) of spend, with the remainder supporting peristomal skin health and appliance adhesion. Estimated average per-patient spend was modelled and varied substantially by nation, from £1073 in Wales to £2354 in England, against a UK average of £2243. Persistent prescribing of ancillary items no longer recommended for routine use (filters, deodorants, bag covers) accounted for an estimated £ 8 million (>2% of spend). Conclusions: PCA data represent an underutilized resource for population-level analysis of ostomy care. Marked inter-nation variation in expenditure, uncertainty surrounding ostomate population estimates, and the continued prescribing of ancillary items not recommended for routine use identify important evidence gaps and generate hypotheses for future research with direct relevance to prescribing policy, resource allocation, and equitable access to care across the United Kingdom.
- 15 September 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (18) , 3019
Open AccessNational Prescribing Patterns in Stoma Care Across the United Kingdom: A Prescription Cost Analysis with Health Policy Implications
Objectives: The prevalence of stoma formation in the United Kingdom has risen markedly over the past decade, yet comparatively little is known about national prescribing patterns for ostomy products. A retrospective cross-sectional observational study was conducted in which the UK Prescription Cost Analysis (PCA) data for 2023 were examined to assess what information can be extracted from these datasets, to evaluate inter-nation variation in prescribing, and identify areas warranting further health economics and policy investigation. Methods: PCA data for calendar year 2023 were collated from the four devolved UK health services. Data on product type, manufacturer, quantities dispensed, and cost were compared across nations and product categories. Results: Total UK prescription spend on ostomy products in 2023 was £457 million, 3.4% of overall NHS prescription expenditure. Pouches accounted for 72% (£329 million) of spend, with the remainder supporting peristomal skin health and appliance adhesion. Estimated average per-patient spend was modelled and varied substantially by nation, from £1073 in Wales to £2354 in England, against a UK average of £2243. Persistent prescribing of ancillary items no longer recommended for routine use (filters, deodorants, bag covers) accounted for an estimated £ 8 million (>2% of spend). Conclusions: PCA data represent an underutilized resource for population-level analysis of ostomy care. Marked inter-nation variation in expenditure, uncertainty surrounding ostomate population estimates, and the continued prescribing of ancillary items not recommended for routine use identify important evidence gaps and generate hypotheses for future research with direct relevance to prescribing policy, resource allocation, and equitable access to care across the United Kingdom.
- Open Access
Characterisation of a Biodegradable Electrode Substrate Based on Psyllium Husk–Carbon Nanoparticle Composites
Unrefined psyllium husk derived from Plantago ovata constitutes a complex mixture of water-soluble and insoluble polymeric chains that form an interpenetrating network capable of entrapping carbon nanoparticles. While the resulting composite was found to swell in aqueous electrolyte, it exhibited hydrogel-like properties where the electrochemical activity was retained and found to be stable upon repetitive voltammetric cycling. Planar film systems were characterized by electron microscopy, Raman spectroscopy, tensile testing, gravimetric analysis, contact angle and cyclic voltammetry. A key advantage of the composite lies in its ability to be cast in 3D geometric forms such as pyramidal microneedle arrays (700 μm high × 200 μm base × 500 μm pitch) that could serve as viable electrode sensors. In contrast to conventional composite electrode materials that rely on non-aqueous solvents, the psyllium mixture is processed entirely from an aqueous solution. This, along with its plant-based origins and simple processing requirements, provides a versatile matrix for the design of biodegradable electrode structures that can be manufactured from more sustainable sources.
Open AccessCharacterisation of a Biodegradable Electrode Substrate Based on Psyllium Husk–Carbon Nanoparticle Composites
Unrefined psyllium husk derived from Plantago ovata constitutes a complex mixture of water-soluble and insoluble polymeric chains that form an interpenetrating network capable of entrapping carbon nanoparticles. While the resulting composite was found to swell in aqueous electrolyte, it exhibited hydrogel-like properties where the electrochemical activity was retained and found to be stable upon repetitive voltammetric cycling. Planar film systems were characterized by electron microscopy, Raman spectroscopy, tensile testing, gravimetric analysis, contact angle and cyclic voltammetry. A key advantage of the composite lies in its ability to be cast in 3D geometric forms such as pyramidal microneedle arrays (700 μm high × 200 μm base × 500 μm pitch) that could serve as viable electrode sensors. In contrast to conventional composite electrode materials that rely on non-aqueous solvents, the psyllium mixture is processed entirely from an aqueous solution. This, along with its plant-based origins and simple processing requirements, provides a versatile matrix for the design of biodegradable electrode structures that can be manufactured from more sustainable sources.